Medicared For All Logo

Prudencio Lucero in Wexford, Pennsylvania

Home Pennsylvania Wexford

Prudencio Lucero has Cardiovascular Disease (cardiology) as his primary medical specialty. Their primary office is: 1000 Stonewood Dr in Wexford, Pennsylvania.

They're a part of the: Wexford Cardiology Inc medical group which has around 2 members. You can call their office at 724-940-6000 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 1988 (around 36 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Prudencio Cuison Lucero Office Phone and Directions

Prudencio Lucero
Wexford Cardiology Inc
1000 Stonewood Dr
Wexford, Pennsylvania 15090
724-940-6000

Patient Ratings
Please rate your experience with Prudencio Lucero below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 724-940-6000


Enter a starting address:


Healthcare Info for Prudencio Lucero

Additional Medical Specialties Include:
INTERVENTIONAL CARDIOLOGY

Medical School: Sorry, his university is not listed
Graduation Year: 1988
The Primary Medical Specialty for Prudencio Lucero is listed as: Cardiovascular Disease (cardiology)
Approximate Years of Experience: 36
PAC (PECOS ID)#: 5991899007
NPI #: 1497751887
NPI Created On: 06/22/2005
NPI Last Updated Listed as: 04/19/2013
Primary Taxonomy Code: 207RC0000X
License Number:
MD050308L
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

  • Highmark Health Insurance Company
  • Highmark Inc.
  • UPMC Health Options, Inc.
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: Tagalog.

Services and Procedures include:

  1. Nuclear medicine study of vessels of heart using drugs or exercise multiple studies
  2. Nuclear medicine study of vessels of heart using drugs or exercise multiple studies
  3. Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report
  4. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report
  5. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision
  6. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report
  7. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
  8. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
  9. Doppler ultrasound study of color-directed heart blood flow, rate, and valve function
  10. Insertion of catheter in left heart for imaging of blood vessels or grafts and left lower heart
  11. Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 15 minutes
  12. New patient office or other outpatient visit, typically 45 minutes
  13. Established patient office or other outpatient visit, typically 15 minutes
  14. Established patient office or other outpatient, visit typically 25 minutes
  15. Initial hospital inpatient care, typically 70 minutes per day
  16. Subsequent hospital inpatient care, typically 15 minutes per day
  17. Subsequent hospital inpatient care, typically 25 minutes per day
  18. Technetium tc-99m sestamibi, diagnostic, per study dose
  19. Injection, regadenoson, 0.1 mg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

They took part in the Million Hearts Initiative, which was deigned to improve cardiac outcomes.

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $20

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783627303

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular

Name of Drug #1: ELIQUIS

Open Associated Drug #1: 0003-0894-31

Payments Total: $18

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783627331

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular

Name of Drug #1: ELIQUIS

Open Associated Drug #1: 0003-0894-31

Payments Total: $19

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783627385

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular

Name of Drug #1: ELIQUIS

Open Associated Drug #1: 0003-0894-31

Payments Total: $22

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783627405

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular

Name of Drug #1: ELIQUIS

Open Associated Drug #1: 0003-0894-31

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832877849

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: CARDIOVASCULAR;METABOLIC DISEASE

Name of Drug #1: ELIQUIS

Open Associated Drug #1: 0003-0893-21

Drug or Biological: Drug

Product Category #2: CARDIOVASCULAR

Name Of Drug #2:: VYNDAQEL

Associated Drug #2: 0069-8729-55

Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 833259537

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: CARDIOVASCULAR;METABOLIC DISEASE

Name of Drug #1: ELIQUIS

Open Associated Drug #1: 0003-0893-21

Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 833382061

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: CARDIOVASCULAR;METABOLIC DISEASE

Name of Drug #1: ELIQUIS

Open Associated Drug #1: 0003-0893-21

Drug or Biological: Drug

Product Category #2: GASTROINTESTINAL

Name Of Drug #2:: COLOGUARD DNA CAPTURE REAGENTS

Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 815311859

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular

Name of Drug #1: Vascepa

Open Associated Drug #1: 52937-101-08

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 815573235

Being Disputed:: No

Product Related: Yes

Drug or Biological: Device

Product Category #1: Cardiac Rhythm Management

Name of Drug #1: Assurity Pacemaker

Cardiovascular Disease (cardiology) Professionals in Wexford

1.
Moneal Shah

12311 Perry Hwy
Wexford, PA
Allegheny Clinic

2.
Moneal Shah

12351 Perry Hwy
Wexford, PA
Allegheny Clinic

3.
Suad Ismail MD

52 Pine Creek Rd
Wexford, PA
Carlton Cardiology Associates Inc

4.
Gregory Smith

52 Pine Creek Rd
Wexford, PA
Carlton Cardiology Associates Inc

5.
Phillip Painley DO

12311 Perry Hwy
Wexford, PA
Allegheny Clinic

6.
Michael Popeck

12311 Perry Hwy
Wexford, PA
Allegheny Clinic

Providers in Wexford Cardiology Inc

1.Prudencio Lucero

1000 Stonewood Dr
Wexford Pa 15090-8386
Wexford Cardiology Inc
Cardiovascular Disease (cardiology)

2.Shelley Savoroski Pa

1000 Stonewood Dr
Wexford Pa 15090-8386
Wexford Cardiology Inc
Physician Assistant

View all 2 members of Wexford Cardiology Inc medical group


Medicared For All
Vote!
Share